Our previous work and that of other investigators strongly suggest a relationship between the upregulation of metalloproteinase-9 (MMP-9) and urokinase-type plasminogen activator receptor (uPAR) in tumor angiogenesis and metastasis. In this study, we evaluated the role of MMP-9 and uPAR in medulloblastoma cancer cell resistance to ionizing irradiation (IR) and tested the antitumor efficacy of siRNA (short interfering RNA) against MMP-9 [plasmid siRNA vector for MMP-9 (pM)] and uPAR [plasmid vector for uPAR (pU)] either alone or in combination [plasmid siRNA vector for both uPAR and MMP-9 (pUM)]. Cell proliferation (BrdU assay), apoptosis (in situ TUNEL for DNA fragmentation), and cell-cycle (FACS) analyses were carried out to determine the effect of siRNA either alone or in combination with IR on G 2 /M cell-cycle arrest in medulloblastoma cells. IR upregulated MMP-9 and uPAR expression in medulloblastoma cells; pM, pU, and pUM in combination with IR effectively reduced both MMP-9 and uPAR expression, thereby leading to increased radiosensitivity of medulloblastoma cells. siRNA treatments (pM, pU, and pUM) also promoted IR-induced apoptosis and enhanced IR-induced G 2 /M arrest during cell-cycle progression. While IR induces G 2 /M cell-cycle arrest through inhibition of the pCdc2-and cyclin B-regulated signaling pathways involving p53, p21/WAF1, and Chk2 gene expression, siRNA (pM, pU, and pUM) alone or in combination with IR induced G 2 /M arrest mediated through inhibition of the pCdc2-and cyclin B1-regulated signaling pathways involving Chk1 and Cdc25A gene expression. Taken together, our data suggest that downregulation of MMP-9 and uPAR induces Chk1-mediated G 2 /M cell-cycle arrest, whereas the disruption caused by IR alone is dependent on p53-and Chk2-mediated G 2 /M cell-cycle arrest. Mol Cancer Res; 9(1); 51-66. Ó2010 AACR.
Introduction
Medulloblastoma is the most prevalent brain tumor in children and has an incidence rate of 0.6 per 1 Â 10 5 patient-years according to the U.S. Central Brain Tumor Registry (1) . Even with multimodal strategies including surgery, radiation, and chemotherapy, tumor recurrence is frequent and most patients eventually die from progressive disease (2) . These treatments also carry significant risks and can lead to long-term disabilities (3) . Consequently, finding novel ways to suppress medulloblastoma growth through low-toxicity therapies is a major goal of several cancer research laboratories. These groups have shown the inhibition of medulloblastoma tumor growth by targeting potent signal molecules (1) .
Ionizing radiation (IR), which is one of the most commonly used therapeutic modalities for several types of cancers, can elicit an activated phenotype that promotes rapid and persistent remodeling of the extracellular matrix (ECM) through the induction of proteases such as urokinase-type plasminogen activator (uPA), urokinase-type plasminogen activator receptor (uPAR), and matrix metalloproteinase-9 (MMP-9; ref. 4) . Both uPA/uPAR and MMP-9 are well-characterized extracellular proteases that are overexpressed in various cancers and known for their role in tumor metastasis and progression (5, 6) . In vitro and in vivo studies have shown that MMP-9 and uPAR levels are closely linked to the degree of tumor cell invasion, and both proteins play key roles in tumor development, angiogenesis, and metastasis by remodeling the ECM and activating cell signaling (7) (8) (9) . uPAR takes the responsibility of activating uPA, a serine protease, leading to degradation of ECM components or indirectly by activating other protease such as MMPs, which, in turn, play a crucial role in ECM dissolution (10) . Apart from the extracellular role, uPAR also activates various intracellular cascades such as MEK/ERK (extracellular signal-regulated protein kinase), PI3-K/Akt (phosphoinositide 3-kinase/serine and threonine kinase), and FAK signaling pathways either by its interaction with other ligands such as vitronectin or through lateral interaction with membrane molecules such as integrins (11) (12) (13) .
Expression of MMP-9 and uPAR can be upregulated by IR, oncogenes, mitogens, growth factors, and binding of integrins to ECM proteins. For example, both radiationenhanced expression and activation of the MMP-9 proteolytic system elevate or modify the bioavailability of several molecules involved in tumor progression (8) . Epidermal growth factor and amphiregulin stimulate MMP-9 secretion in the SK-BR-3 human breast cancer cell line (14) and prostate cancer cells (15) . In addition, expression of oncogenic Ras and Src in cancer cells also led to the expression of MMP-9, suggesting that various stimuli may activate cellular signaling pathways, which are controlled by these oncoproteins, to upregulate MMP-9 (16) . Induction of MMP-9 is also regulated through cell-cell contacts and cell-ECM interaction. For example, fibroblasts cultured with colon carcinoma cells were induced to secrete MMP-9 (17) . Generally, factors that upregulate the uPA-uPAR complex also upregulate MMP-9, suggesting that they may be coregulated (14) . This suggests that inhibition of these molecules could be a potential therapeutic approach to improve the efficacy of radiotherapy. Nevertheless, several MMP inhibitors have shown to be disappointing in clinical trials phase due to either lack of benefits or major adverse effects (18) . Therefore, a strong rationale exists in the development of improved therapeutic strategies targeting MMPs and uPAR in cancer care.
RNA interference-based, targeted silencing of gene expression is a strategy of potential interest for cancer therapy (19, 20) . Furthermore, the specificity and potency of short interfering RNA (siRNA) for MMP-9 and uPAR in cell culture and animal studies suggest that it has the potential to be a powerful therapeutic agent (9, 21) . In the past, viral vectors, particularly adenoviruses, have been the primary vehicles of choice for gene transfer. However, the ability of adenoviral proteins to trigger an immune response and the limited length of time that gene expression can be maintained in the target cells are major concerns. Plasmid-based vectors, therefore, may provide a safer, more efficient mode of delivery (22) .
Attempts are currently being made to overcome the adverse effects and limitations of radiation therapy by using a combination of gene therapy and radiotherapy. In this study, we combined radiation along with downregulation of MMP-9 and uPAR, which was achieved using siRNAexpressing plasmid vector for MMP-9 (pM), uPAR (pU), and plasmid siRNA vector for both uPAR and MMP-9 (pUM) in medulloblastoma cells. Our results show that the simultaneous downregulation of these proteases had an additive effect in inhibiting medulloblastoma cell proliferation. The results of this study show that the simultaneous knockdown of uPAR and MMP-9 by using RNAi plasmid vectors can be successfully utilized and presents a potential therapeutic tool for medulloblastoma treatment. Furthermore, our results indicate that after the combined treatment, molecules associated with cell survival and cell cycle were downregulated, resulting in cell-cycle arrest and increased apoptosis in both DAOY and D283 cells.
Materials and Methods

Cell culture and transfection conditions
Human medulloblastoma cell lines DAOY and D283 were purchased from American Type Culture Collection and cultured at 37 C in an atmosphere of 5% CO 2 in advanced MEM for DAOY cells and improved MEM (zinc option) for D283 cells. The medium was supplemented with 10% FBS, 100 units of penicillin, and 100 mg/mL of streptomycin. FuGENE HD reagent was utilized for transient transfection as per the manufacturer's instructions. Briefly, DAOY cells were cultured in 100-mm plates until 50% to 60% confluence was reached, followed by 2 washes with serum-free medium. Afterward, 7 mg of plasmid DNA were mixed with 20 mL of FuGENE HD transfection reagent (Roche) in 400 mL of serum-free medium for 30 to 45 minutes at room temperature. The mixture was added to the cells for 8 to 10 hours in a CO 2 incubator at 37 C. After transfection, the medium was replaced with serumcontaining medium and incubated for another 26 to 28 hours. Cells were harvested for isolation of total RNA or whole-cell lysates for further analysis.
siRNA constructs
In the present study, we used plasmid constructs expressing siRNA against either MMP-9 (pM), uPAR (pU) alone (monocistronic), or in combination of both uPAR and MMP-9 siRNA sequences (pUM, a bicistronic construct). siRNA sequences used to target MMP-9 and uPAR and the construction of the above siRNA vectors and pSV (a pcDNA3.1 vector carrying a scrambled nucleic acid sequence) were described in our earlier work (9) . For the overexpression vectors, we purchased full-length MMP-9 and uPAR from Origene. We purchased siRNA oligos for Chk1 from (Santa Cruz Biotechnology) and shRNA plasmid constructs against p53 from Addgene.
Western blotting
Equal amounts of protein from cell lysates in 1Â SDS loading buffer were separated by SDS-PAGE, transferred onto nitrocellulose membranes, and incubated with primary antibodies. Enhanced chemiluminescence system was used to detect immunoreactive proteins with horseradish peroxidase-conjugated secondary antibodies. We purchased the following antibodies from Biomeda, Cell Signaling, and Santa Cruz Biotechnology: anti-p53, anti-phos-p53, antip27, anti-p21, anti-Cdc2, anti-phos-Cdc2, anti-cyclin B1, anti-cyclin A, anti-ERK1, anti-phos-ERK1, anti-p38, anti-Akt, anti-phos-Akt, anti-PI3-K, anti-MEK-1/2, antiChk1, anti-Chk-2, anti-Cdc25A, anti-Ras, anti-Raf, antiuPAR, anti-MMP-9, and anti-GAPDH.
Real-time PCR
Total RNA was isolated from control and transfected cells using TRIzol following standard protocol. Total RNA was treated with DNase I (Invitrogen). First strand cDNA was prepared by using Superscript III reverse transcriptase (Invitrogen). First strand cDNA (100 ng) was used in quantitative real-time-PCR (qRT-PCR), using sequence specific primers for MMP-9, uPAR, and GAPDH (glyceraldehyde-3-phosphate dehydrogenase; Table 1 ). qRT-PCR was carried out using FastStart SYBR Green master mix (Roche Applied Science) on a Bio-Rad IQCycler Detection system (Bio-Rad) as per the manufacturer's instruction. The relative mRNA expression levels of MMP-9 and uPAR mRNA expression levels were calculated on the basis of mean GAPDH expression levels of the representative sample.
BrdU assay for cell proliferation
Cells (5 Â 10 3 cells/well) were cultured on 96-well plates for 12 to 72 hours and incubated for 12 hours with 5 mmol/ L of 5-BrdU reagent (Labeling and Detection Kit I; Roche) and fixed in Fixodent. An anti-BrdU antibody was added, and the immune complexes were detected by subsequent substrate reaction. The reaction product was quantified at dual wavelengths of 450/540 nm using a scanning multiwell spectrophotometer. Developed color and absorbance values correlated with the amount of DNA synthesis. Unscheduled DNA synthesis due to repair was determined after blocking DNA replication with 5 mmol/L of hydroxylurea.
Cell-cycle analysis by fluorescence-activated cell sorting
The distribution of cells in various cell-cycle phases was determined using fluorescence-activated cell sorting (FACS) analysis of DNA content. Exponentially growing cells (1 Â 10 6 cells) were plated in 100-mm plates and cultured overnight at 37 C. Then, cells were transfected for 48 hours. Cells were collected and washed twice with sterile 1Â PBS. Cells were collected and fixed by resuspension in 1 mL of 70% ethanol for 2 to 3 minutes, centrifuged at 900 Â g for 2 minutes, and washed in ice-cold 1Â PBS. The cell pellets were resuspended in 1 mL of 1Â PBS containing 50 mg/mL of propidium iodide (Sigma-Aldrich Chemical Co.) and 100 mg/mL of RNase (Invitrogen), incubated at 4 C for 30 minutes, and then analyzed using a FACScan flow cytometer (Becton Dickinson).
TUNEL assay
We used the TUNEL (terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling) apoptosis detection kit (Upstate Co.) to carry out DNA fragmentation/fluorescence staining. Briefly, transfected cells in 8-well chamber slides were incubated with a reaction mix containing biotindUTP and terminal deoxynucleotidyl transferase for 60 minutes at room temperature. Fluorescein-conjugated avidin was applied to each sample, followed by incubation in the dark for 30 minutes. Positively stained fluoresceinlabeled cells were visualized and photographed using fluorescence microscopy.
DNA laddering assay
Fragmented DNA was extracted from cells transfected with siRNA alone or in combination with IR following the method previously described by Gong et al. (23) . Treated cells were resuspended in PBS, fixed in 1.5 mL of chilled 70% ethanol, and stored at À20 C overnight. Cell pellets were incubated at room temperature for 30 minutes after being resuspended in 40 mL of phosphate-citrate buffer (192 mmol/L of Na 2 HPO 4 , 4 mmol/L of citrate, pH 7.8).
To the supernatant, 3 mL aliquots each of 0.25% Nonidet P-40 and RNase A (1 mg/mL) were added to the extracts and incubated at 37 C for 1 hour. Proteinase K was added to 100 mg/mL and incubation was continued for another hour. An aliquot of each DNA extract was analyzed on a 1.6% agarose gel.
Immunoprecipitation and Western blot analyses
Cytosolic extracts from medulloblastoma cells and derivatives were prepared as described by Chang et al. (24) . Collected cells were swollen in equal volume of hypotonic buffer (20 mmol/L HEPES-KOH, pH 8.0, 5 mmol/L KCl, 1.5 mmol/L MgCl 2 , 0.1 mmol/L DTT) containing 5 mmol/L sodium butyrate and a protease inhibitor cocktail (Sigma), homogenized by Dounce homogenizer, and centrifuged at 1,500 Â g to separate the nuclei pellet fraction. The supernatants were further centrifuged at 20,000 Â g for 20 minutes. Nuclei pellets were washed twice with MNase buffer (10 mmol/L Tris-HCl, 1 mmol/ L MgCl 2 , 1 mmol/L CaCl 2 ), and suspended in buffer containing MNase (3 units/mL), followed by incubation at 28 C for 30 minutes. After centrifugation at 16,000 Â g for 15 minutes, supernatants were used as the nucleosomal fractions. The protein concentration of the cell lysates was determined (Protein Assay Kit; Bio-Rad). Five hundred micrograms of lysate was incubated with preimmune 
serum (2.5 mL) containing Protein A Sepharose 6MB (Pharmacia) for 1 hour, and the lysate was clarified by brief centrifugation in a microcentrifuge at 15,000 rpm. The lysate was incubated with 10 mg of cyclin B1 antibody or nonspecific mouse anti-IgG and 50 mL Protein A Sepharose 6MB overnight at 4 C with continuous mild agitation. Sepharose beads were washed 3 times in cell lysis buffer, and the bound proteins were eluted in SDS gel loading buffer by boiling. Immunoblotting was carried out by chemiluminescence (ECL System; Amersham) according to the manufacturer's instructions.
Densitometry
ImageJ software (National Institutes of Health) was used to quantify the mRNA and protein band intensities. Data are represented as relative to the intensity of the indicated loading control.
Statistical analysis
Statistical comparisons were carried out using ANOVA for analysis of significance between different values using GraphPad Prism software. Values are expressed as mean AE SD from at least 3 separate experiments, and differences were considered significant at a P value of less than 0.001.
Results
pM, pU, and pUM transfection inhibits radiationinduced MMP-9 and uPAR expression at both the mRNA and protein levels in medulloblastoma cells
To study the effects of pM, pU, and pUM, alone or in combination with IR, we transfected DAOY and D283 cell lines and conducted a quantitative real-time (RT) PCR to determine MMP-9 and uPAR expression at the mRNA level. qRT-PCR analysis showed that pM, pU, and pUM transfection inhibited MMP-9 and uPAR expression at the mRNA level when compared with mock or pSV-transfected cells in both the medulloblastoma cell lines. In contrast, IR augmented the expression of uPAR by nearly 2-fold in both cell lines (Fig. 1A) . The increase in MMP-9 expression upon IR treatment was observed to be nearly 4-and 1.3-folds in DAOY and D283 cells, respectively, compared with nonirradiated cells. Treatment with siRNA in combination with IR inhibited expression of these proteases more than siRNA treatment alone. MMP-9 and uPAR expression levels were reduced by nearly 4-and 2.5-folds in the pUM-treated cells (DAOY and D283 cells, respectively) when compared with mock and pSV treatments. The MMP-9 and uPAR transcripts levels were reduced by more than 4-fold, in both DAOY and D283 cells, when treated with siRNA plus IR compared with the cells either treated with IR alone or IR plus pSV (Fig. 1A) .
Western blot analysis using respective antibodies against MMP-9 and uPAR confirmed the RT-PCR analysis results (Fig. 1B) ; MMP-9 and uPAR levels were reduced by nearly 40% and 33%, respectively, in the pUM-treated cells as compared with the mock and pSV treatments and by more than 90% and 120%, respectively, when cells were transfected with pUM in combination with radiation compared with cells treated with radiation alone (Fig. 1C) . In the cells treated with radiation alone, MMP-9 and uPAR levels increased by 35% and 50%, respectively, as compared with the control cells.
pM, pU, and pUM transfection inhibits cell proliferation in medulloblastoma cells
For the quantitative determination of cellular proliferation and activation, we carried out the BrdU assay. We carried out the assay after DAOY and D283 cells were transfected with pSV, pM, pU, or pUM alone or in combination with IR at various time points. We have not observed any significant reduction in proliferation of siRNA-transfected or IR-treated cells at the 24-hour time point, but we observed a gradual and significant reduction by the 72-hour time point (P < 0.001; Fig. 1D ), indicating that cells were losing their viability. The viability of DAOY cells transfected with pUM was reduced by nearly 55% and 68% compared with pSV-transfected cells alone or in combination with IR, respectively. In the case of D283 cells, the percent viability after transfecting with pUM was reduced by nearly 30% and 40% compared with pSVtransfected cells alone or in combination with IR, respectively (Fig. 1D) .
pM, pU, and pUM transfection enhances G 2 /M arrest in medulloblastoma cells
FACS analysis of cells transfected with siRNA (pM, pU, and pUM) alone or in combination with IR shows an accumulation of cells in G 2 /M as compared with the control (mock) or pSV-transfected cells (Fig. 2) . Quantification of the FACS data shows a 2-to 3-fold increase in the number of cells arrested in G 2 /M in the DAOY ( Fig. 2A) and D283 (Fig. 2B ) cells transfected with pM, pU, and pUM, alone or in combination with IR, as compared with pSV or mock treatments ( Fig. 2A and B) . We observed no significant differences in the cell-cycle pattern between nonradiated and irradiated DAOY cells. In contrast to this, FACS analysis of D283 cells with IR treatment showed an accumulation of cells in the G 2 /M phase compared with nonirradiated cells. Apart from this, a minor but a significant number of cells were consistently noticed to be accumulated at the polyploidy (>4n; possibly octaploidy) DNA phase, which seems to be prominent in cells transfected with siRNA (pM, pU, and pUM) alone or in combination with IR (Fig. 2B) .
pM, pU, and pUM transfection downregulates radiation-induced Ras, Raf, PI3-K, MEK1/2, and ERK1/2 expression levels in medulloblastoma cells
To study the effects of pM, pU, and pUM, alone or in combination with IR, in DAOY and D283 cells on intracellular signaling pathways, we determined the expression of Ras, Raf, PI3-K, Akt, MEK1/2, ERK1/2, and p38 at the protein level. Western blot analysis showed that siRNAmediated downregulation of uPAR and MMP-9 inhibited the basal levels of Ras, Raf, MEK1/2, and PI3-K. Furthermore, we also noticed that pM, pU, and pUM transfection inhibited the phosphorylation levels of pERK1/2, p38, and Akt as compared with mock or pSV-transfected medulloblastoma cells (Fig. 3A) . The levels of PI3-K, MEK1/2, and phosphorylation levels of ERK1/2, Akt, and p38 were reduced by 2-to 4-fold in pUM-treated cells when compared with IR-treated mock and pSV-transfected cells ( Fig. 3B and C) . In contrast, treatment with radiation alone augmented the expression/phosphorylation levels of Ras, Raf, PI3-K, pERK1/2, and pp38. However, the siRNA treatment prior to IR treatment has significantly reduced the expression of Ras, Raf, PI3-K, and MEK1/2, and the phosphorylation levels of ERK, Akt, and p38 levels by more than 2-fold, compared with the cells treated with radiation alone. Conversely, in the cells that were treated with radiation alone, the expression levels of Ras, PI3-K, and ERK1/2 were 30% to 80% higher than those in the mock cells ( Fig. 3B and C) . The levels of GAPDH remained unchanged in all treatment groups (Fig. 3A) .
Downregulation of MMP-9 and uPAR modulates G 2 /M cell-cycle regulatory molecules
To study the disparity in G 2 /M cell-cycle molecule expression between mock and siRNA-transfected cells (pM, pU, and pUM alone or in combination with IR), we carried out immunoblot analysis. The levels of Chk1, Chk2, and p21 were observed to be increased in the medulloblastoma cells transfected with pM, pU, and pUM in combination with IR treatment compared with Figure 1 . Effect of pM, pU, or pUM alone or in combination with radiation on MMP-9 and uPAR expression levels and viability of DAOY and D283 medulloblastoma cells. A, DAOY and D283 cells were transfected with mock (1% PBS), pSV, or siRNA against MMP-9 and/or uPAR (pM, pU, and pUM). After 36 hours of incubation, cells were irradiated with 8 Gy and incubated for a further 12 hours. Total RNA isolated from the transfected cells were used in determining the expression levels of MMP-9 and uPAR by qRT-PCR method. Relative expression levels of the gene were graphically represented. Expression of GAPDH was used to verify uniform levels of cDNA. B, total cell lysates were used to determine MMP-9 and uPAR levels using Western blot analysis. GAPDH served as a loading control. C, the band intensities of MMP-9 and uPAR were quantified by densitometry. Columns, mean of triplicate experiments; bars, SD; * and **, P < 0.05, and ***P < 0.001, the significant difference from either mock or pSV. D, effect of pM, pU, or pUM alone or in combination with radiation on cell proliferation. DAOY and D283 cell proliferation was determined by BrdU assay. 5 Â 10 3 DAOY and D283 cells were transfected with mock (1% PBS), pSV, pM, pU, or pUM alone or in combination with IR. After 36 hours of incubation, cells were irradiated with 8 Gy and incubated for different time intervals (24, 36, 48, 60 , and 72 hours). The percent viability was calculated as a ratio of mean absorbance of sample to mean absorbance of mock multiplied by 100, and values were plotted. Points, means of 3 experiments; bars, SD. In contrast, we observed a decrease in the levels of p53, pp53, p27, Cdc25A, Cdc25B, Cdc1, Cdc2, cyclin A, and cyclin B1 in the cells after transfection with pM, pU, and pUM (in combination with IR treatment) compared with IR treatment alone (Fig. 4A) . As revealed by densitometry, the protein levels of Chk1 was up regulated by nearly 2-folds in cells transfected with siRNA plus IR treatment compared with mock or pSV-transfected cells ( Fig. 4B and  C) , whereas pp53, p27, Cdc25A, Cdc25B, Cdc2, cyclin A, and cyclin B1 were downregulated up to 2-to 3-fold ( Fig. 4B and C) in the cells treated with siRNA (pM, pU, and pUM) alone or in combination with IR. Treatment with IR alone increased Cdc25A and pp53 expression levels by more than 30% and 65%, respectively, in DAOY cells (Fig. 4B ) and 120% and 72%, respectively in D283 cells (Fig. 4C ) as compared with mock and pSV treatments.
Radiation and downregulation of MMP-9 and uPAR induce apoptosis in medulloblastoma cells
BrdU assay and FACS analysis indicated that siRNA treatment alone or in combination with IR has significantly reduced cell proliferation and increased accumulation of cells in the polyploidy state, suggesting that the abovementioned siRNA treatment might induce apoptosis in medulloblastoma cells. Hence, we made an attempt to determine the possible induction of apoptosis in MMP-9 and uPAR downregulated medulloblastoma cells by using TUNEL assay. We noticed that downregulation of either MMP-9 or uPAR alone has significantly induced apoptosis in nearly 40% of the cells. In addition, the number of apoptotic cells increased up to 75% when the cells were transfected with pUM compared with mock or pSV-transfected cells. TUNEL-positive, apoptotic medulloblastoma cells were meagerly present in control or pSV-transfected cells (Fig. 5A and B) . In addition, transfection with pM, pU, A B Figure 2 . Effect of pM, pU, or pUM alone or in combination with radiation on DNA content of DAOY and D283 medulloblastoma cells. DAOY and D283 cells were transfected with mock (1% PBS), pSV, pM, pU, and pUM. After 36 hours of incubation, cells were irradiated with 8 Gy and incubated for a further 12 hours. To determine cell cycle arrest, the DNA content of medulloblastoma cells was measured by FACS analysis. Representative images of (A) DAOY) and (B) D283 from each treatment were given. Relative expression levels (arbitrary units) Figure 3 . Effect of pM, pU or pUM alone or in combination with radiation on selected signaling pathways in medulloblastoma cells. DAOY and D283 cells were transfected with mock, pSV, pM, pU, and pUM. After 36 hours of incubation, cells were irradiated with 8 Gy and incubated for a further 12 hours. A, Ras, Raf-1, PI3-K, Akt, pAkt, MEK1/2, ERK, pERK, and p38 protein expression levels were determined by Western blotting. GAPDH served as a control to confirm equal loading of cell lysates. B, DAOY. C, D283. The band intensities of Ras, PI3-K, pAkt, MEK1/2, and pERK were quantified by densitometry. Columns, mean of triplicate experiments; bars, SD; ***, P < 0.005, the significant difference from either mock or pSV. . Effect of downregulating MMP-9 and uPAR in combination with IR on G 2 /M cell-cycle regulatory molecules. A, Western blot analysis was carried form the total cell lysates extracted from siRNA-transfected cells (alone or in combination with IR treatment). Chk1, Chk2, p53, phospho-p53, p21, p27, Cdc25A, Cdc25C, Cdc2, pCdc2, cyclin B1, and cyclin A protein expression levels were determined by Western blotting. GAPDH served as a control to confirm equal loading of cell lysates. B, DAOY. C, D283. The band intensities of Chk1, Cdc25A, pCdc2, and cyclin B1 were quantified by densitometry. Columns, mean of triplicate experiments; bars, SD; ***, P < 0.001, the significant difference from either mock or pSV. and pUM in combination with IR resulted in higher number of TUNEL-positive cells than with mock, pSV, mock þ IR, or pSV þ IR treatments alone (Fig. 5A and B) . The present results showed that pUM transfection in combination with irradiation resulted in 85% more TUNEL-positive cells than treatment with IR alone. These data confirm that the downregulation of active MMP-9 and uPAR increases sensitivity to IR. Induction of apoptosis in cells transfected with siRNA alone or in combination with IR was confirmed by carrying out DNA laddering assay. When DNA isolated from treated cells was analyzed on a agarose gel, we noticed a smear representing DNA fragmentation in cells treated with pM, pU, and pUM either alone or in combination of IR, whereas the mock or cells transfected with pSV showed no DNA fragmentation ( Supplementary Fig. S1 ).
Overexpression of MMP-9 and uPAR modulates expression of pAkt, Chk1, pCdc2, and cyclin B1
To better understand the molecular mechanism(s) underlying upregulated MMP-9 and uPAR, Chk1-dependent attenuation of G 2 /M arrest, we transfected medulloblastoma cells with vectors expressing full-length MMP-9 (pFL-M) and uPAR (pFL-U) and measured changes in proteins that are implicated in the G 2 /M transition. We found that the expression of MMP-9, uPAR, and phosphorylated form of Akt levels were upregulated by 2-to 3-fold in both DAOY and D283 cells transfected with pFL-M and pFL-U (Fig. 6A) . Under the same conditions, Western blot analysis showed that overexpression of MMP-9 and uPAR has significantly downregulated Chk1 expression by 2-fold in both DAOY and D283 cell lines (Fig. 6B and C) . However, the expression levels of pCdc2 and cyclin B1 remained the same in mock and pFL-M-and/or uPAR-transfected cells (Fig. 6A) . This result is an indication that MMP-9 and uPAR negatively regulates Chk1 expression in medulloblastoma cell lines.
Effect of downregulation of Chk1 on the expression levels of MMP-9, uPAR, Chk2, pCdc2, and cyclin B1
To better understand the molecular mechanism(s) underlying MMP-9 and uPAR-upregulated, Chk1-dependent attenuation of G 2 /M arrest, we transfected cells with siRNA for Chk1 alone or in combination with pM, pU, or pUM and determined any changes in proteins associated with the G 2 /M shift (Fig. 7A) . We observed that the protein levels of Cdc25A, pCdc2, and cyclin B1 with siRNA for Chk1 alone Figure 6 . A, effect of overexpression of MMP-9 and uPAR on selected signaling molecules in DAOY and D283 cells. Medulloblastoma cells were transfected with pFL-M and pFL-U for 48 hours. Cells were harvested, and Western blotting was carried out for MMP-9, uPAR, pAkt, Chk1, pCdc2, and cyclin B1 in total cell lysates. GAPDH served as a loading control. Results are representative of 3 independent experiments. B, band intensities of signaling molecules were quantified by densitometry. Columns, mean of triplicate experiments; bars, SD; ***, P < 0.001, the significant difference from either mock or pEV. Figure 7 . Effect of pM, pU, pUM, or Chk1 siRNA either alone or in combination on selected signaling molecules in DAOY and D283 cells. Medulloblastoma cells were transfected with either Chk1 siRNA alone or in combination with pM, pU, or pUM for 48 hours. A, cells were harvested, and Western blotting was carried out for Chk1, MMP-9, uPAR, Cdc25A, pCdc2, and cyclin B1 in total cell lysates. GAPDH served as a loading control. Results are representative of 3 independent experiments. B, the band intensities of signaling molecules were quantified by densitometry. Columns, mean of triplicate experiments; bars, SD; ***, P < 0.001, the significant difference from either mock or pSV. C, effect of radiation or p53 siRNA alone or in combination on selected signaling molecules in DAOY and D283 cells. Medulloblastoma cells were transfected with p53 siRNA for 36 hours. Cells were then irradiated with 8 Gy and incubated for a further 12 hours. Cells were harvested, and Western blotting was carried out for p53, p21, MMP-9, uPAR, Chk2, p21, pCdc2, and cyclin B1 in total cell lysates. GAPDH served as a loading control. Results are representative of 3 independent experiments. D, the band intensities of signal molecules were quantified by densitometry. Columns, mean of triplicate experiments; bars, SD; ***, P < 0.001, the significant difference from either mock or pSV. or in combination with pM, pU, or pUM were up regulated by nearly 2-to 3-fold compared with control siRNA-treated cells (Fig. 7B) . We did not observe any significant differences in the expression levels of MMP-9 and uPAR between the pSV-and Chk1 siRNA-treated cells (Fig. 7B) . These results indicate that Chk1 is regulated by both MMP-9 and uPAR and only Chk1 controls downstream molecules such as Cdc25A, pCdc2, and cyclin B1.
D283 D283
Effect of downregulation of p53 on MMP-9, uPAR, Cdc25A, pCdc2, and cyclin B1
To better understand the molecular mechanism(s) underlying IR-upregulated, p53-dependent attenuation of G 2 /M arrest, we transfected cells with siRNA for p53 alone or in combination with IR and determined any changes in proteins associated with the G 2 /M shift (Fig. 7C) . Specifically, we measured for protein levels of MMP-9, uPAR, p53, Chk2, p21, pCdc2, and cyclin B1. p53 siRNA transfection upregulated pCdc2 and cyclin B1 by nearly 2-fold ( Fig. 7C and D) , whereas p53, p21, and Chk2 were downregulated by 2-fold ( Fig. 7C and D) . We did not observe any significant differences in MMP-9 and uPAR with p53 siRNA-transfected cells.
Immunoprecipitation
To better understand the interaction of cyclin B1 with pCdc2 and Cdc25A, we carried out an immunoprecipitation assay. DAOY and D283 cells were treated as described earlier in the Material and Methods section, and cytosolic and nuclear fractions were obtained from different treatment groups. Both cytosolic and nuclear fractions were subject to immunoprecipitation with cyclin B1 antibody. Using Western blotting, we detected the immunoprecipitates for Cdc25A and pCdc2. The nuclear extracts of siRNA-treated (pM, pU, and pUM) cells indicated significantly decreased levels of pCdc2 and Cdc25A as compared with mock or pSV-transfected DAOY and D283 cells (P < 0.001; Fig. 8 ). Furthermore, we observed that pCdc2 and Cdc25A levels were higher in the cytosolic fractions of treated and untreated cells than in their nuclear counterparts. These results indicate that cyclin B1 binds to pCdc2, which, in turn, moves from the nucleus to cytoplasm (Fig. 8) .
Discussion
The purpose of this study was to examine the effect of combining the downregulation of MMP-9 and uPAR with radiation on medulloblastoma cells. Radiation-induced MMP-9 and uPAR lead to enhanced tumor growth, angiogenesis, and metastasis (8, 9, 21) . Thus, the observed radiation-induced increase in MMP-9 and uPAR activity is not only integral to the tumor invasion but may also aid survival in a relatively aggressive setting. Our results show that pM, pU, and pUM transfection of irradiated DAOY and D283 cells significantly inhibited radiation-enhanced MMP-9 and uPAR activity at both the mRNA and protein levels and their associated tumorigenic properties such as cell proliferation (Fig. 1) . Our results also show that the decreased expression of MMP-9 and uPAR further altered important downstream signaling molecules that direct the cells towards cell-cycle arrest. siRNA for MMP-9 negatively regulates breast cancer cell proliferation without stimulating metastasis (25) . MMP-9 inhibition has been shown to increase senescence and programmed cell death in medulloblastoma cells (26, 27) .
In the present study, radiation and downregulation of MMP-9 and uPAR caused cell-cycle arrest and induced apoptosis in medulloblastoma cells as shown by FACS analysis and TUNEL staining. FACS analysis confirmed that siRNA treatment alone or in combination of IR reduced the number of cells in the G 1 phase and induced G 2 /M arrest in both DAOY and D283 cell lines. On the other hand, D283 cells exposed to either IR or siRNA treatment (alone or in combination) induced accumulation of a small proportion of octaploid (polyploid) cells. Similar to these results, it was earlier reported that irradiated tumor cells lines (Ramos, Namalwa, WI-L2-NS, Jurkat, and HeLa cell lines) underwent an extensive endoreplication and increased their DNA contents (28, 29) . Likewise, further studies showed that the accumulation of cell fractions in the polyploidy (tetraploidy and octaploidy) phase was higher in hepatocytes treated with a combination of TNFa and radiation than with TNFa treatment alone (30) . Similarly, in the present study, we observed that the accumulation of polyploidy cell fractions was prominent in cells transfected with siRNA in combination with IR when compared with IR or siRNA treatment alone. The accumulation of cells in the polyploidy stage resulted in either decreased cell proliferation or induced apoptotic stress, and the same was observed in the present study (BrdU and TUNEL assays). siRNA treatment, followed by irradiation of the cells, has significantly increased the accumulation of cell fraction in polyploidy phase, which ultimately decreased the proliferation and increased the number of apoptotic cells compared with mock or pSV-transfected cells.
Adair et al. (31) observed that the levels of MMP-9 and uPA were elevated after radiation in a patient with an astrocytoma, which was managed by partial resection and external beam irradiation at maximal tolerable doses. Furthermore, radiation enhanced the migration and invasiveness of brain tumor cells in association with enhanced expression/activity of MMP-9 and uPAR (32) . Our previous findings, suggesting that ERK1/2 and Akt activation plays a key role in cell survival pathways, have been further confirmed and characterized by other groups (33) . In addition, it was shown that the phosphorylation of ERK and Akt is a key event for apoptotic cells (34) . Ras and its downstream effectors alter the expression of many molecules that regulate the cell cycle, including p53 and p21, and can lead to cell-cycle arrest (35) . p53 has been shown to alter the expression of phosphatases, which regulate the activity of Raf/MEK/ERK, or stimulate the transcription of Raf/MEK/ERK genes (36) . After DNA damage, p53 may activate the phosphatases that serve to fine-tune the Raf/MEK/ERK cascade. In contrast, after growth factor stimulation, p53 may induce MAP kinase phosphatase (MKP1) or other phosphatases that alter the activity of the Raf/MEK/ERK cascade (35) . Recent studies have shown that activation of PI3-K/Akt pathway components can override DNA damage-induced or chemotherapeutic agent-induced growth arrest at the G 2 /M phase of the cell cycle (37) . There are several candidates, including FOXO3a and Chk1, regulated by Akt pathway that are involved in the regulation of the G 2 /M transition (38) . Upstream elements of the checkpoint pathways include ATM and ATR kinases, which primarily phosphorylate and activate Chk1 and Chk2 (39) . While the ATMChk2 pathway is activated primarily by radiation-induced DNA damage (40) , the ATR-Chk1 pathway is induced primarily by stalled DNA replication (39) .
To elucidate the mechanisms by which MMP-9 and uPAR activation affect G 2 /M arrest in damaged cells, we investigated their effects on cell-cycle molecules, such as Chk1, Chk2, cyclin B1, Cdc2, and cyclin A, which are critical determinants of the G 2 /M transition (41) . It has Figure 8 . Immunoprecipitation analysis. DAOY and D283 cells were transfected with mock, pSV, pM, pU, and pUM. After 36 hours of incubation, cells were irradiated with 8 Gy and incubated for a further 12 hours. DAOY (A) and D283 (B) total cell lysates were immunoprecipitated with anticyclin B1 antibody, separated on 10% SDS-polyacrylamide gels, and transferred to nitrocellulose. Cyclin B1 was quantitated with both anti-pCdc2 and anti-Cdc25A antibodies and ECL detection. C, the band intensities of signal molecules were quantified by densitometry. Columns, mean of triplicate experiments; bars, SD; P < 0.001, the significant difference from either mock or pSV. been reported that various stresses to cause a decrease in cyclin B1/pCdc2 activity accompanied by G 2 /M cell-cycle arrest. The major mechanism of such arrest seems to involve the inhibitory phosphorylation of Cdc2 at Tyr14/15 (42) . It is believed that the major mechanisms underlying DNA damage-induced Cdc2 inhibitory phosphorylation includes the upregulation of p53 and the downregulation of Cdc25A and Cdc25C phosphatases by the Chk1 kinase (43, 44) . Simultaneous downregulation of MMP-9 and uPAR changes Chk1 activity and affects the expression/function of these key components involved in DNA damage response. Also, it is clear that radiation induces G 2 /M cell-cycle arrest through the p53-mediated pathway in both DAOY and D283 cells.
In the present study, we show that the treatment of medulloblastoma cells with IR resulted in the upregulation of p53 and its phosphorylated form. The p53 tumor suppressor gene is involved in different cellular processes, including regulation of the cell cycle, DNA repair, cell differentiation, angiogenesis, senescence, and apoptosis (45) . These activities are mediated through a variety of biochemical functions, such as transcriptional activation, transrepression, DNA annealing, and 3 0 ,5 0 -exonuclease activity, which required a large set of target gene products and interacting proteins (46) . The increase in p53 protein levels, which occur in response to genotoxic stress, is thought to result in transcription of target genes that mediate the varied functions associated with the p53 gene.
We further investigated the influence of radiation on p21 expression levels in DAOY and D283 cells. Our results show an increase in the expression of p21, a downstream element of p53 that is known for its role in G 2 /M cell-cycle arrest (47) . In response to DNA damage, cells undergo G 2 / M arrest in a p53-dependent manner. Our results clearly confirmed that G 2 arrest is caused by overexpression of p53. This mechanism is mediated through transcriptional activation of the p21 gene. Because of the negative roles of p53 and p21 in cell-cycle progression, it is possible that p53 and p21 are functionally linked.
The cell cycle is controlled by a highly conserved family of cyclin-dependent kinases (Cdk) and their regulatory subunit cyclins. Among the cyclins, cyclin B1 plays a pivotal role as a regulatory subunit for Cdk1, which is indispensable for the transition from G 2 to M phase. Cyclin B1 is one of the target genes of the transcription factor p53 (48) . The effects of p53 may be more complicated than previously thought. The fact that a constitutively active nuclear cyclin B1 is needed to abrogate arrest suggests that p53 may alter the nuclear/ cytoplasmic shuttling of cyclin B1 (49) . Our results clearly show that siRNA-mediated p53 silencing reduces IRinduced p53 and p21 expression and significantly increased pCdc2 and cyclin B1 expression (Fig. 5C ). Cyclin B1 RNAi knockdown studies has shown that cyclin B1, cyclin A, and Cdk2 protein levels were downregulated whereas Cdc2 protein levels were almost unaffected in HeLa cells (50) .
Cyclin B1, the regulatory subunit of cyclin-dependent kinase 1 (Cdk1), is essential for the transition from G 2 to mitosis. The entry into mitosis depends on phosphorylation and activation of Cdc25C, which dephosphorylates and activates the Cdk1-cyclin B complex (51) . Cdc25A activity progressively increases from the G 1 /S transition until mitosis (52) . The cyclin B1 binding site on Cdc25A is in close proximity to a 14-3-3-s binding site for which the residue T507 is essential. Chen et al. (53) have speculated that Chk1 phosphorylates T507 on Cdc25A throughout the cell cycle. In the present study, as shown by Western blotting, downregulation of MMP-9 and uPAR decreased the expression levels of cyclin B1 and Cdk1 (Fig. 3B) . Abe et al. (54) also showed an increase in Cdk1 expression levels but a decrease in cyclin B1 levels. Similar results were observed in breast cancer cells (55) . Overexpression of p53 and Chk1 not only induces cell-cycle arrest but also enhances apoptosis (56) . In addition, radiation-induced p53 can stimulate p21, a protein that sequesters cyclin B1-Cdk1 complexes out of the nucleus.
In summary, radiation alone or in combination with siRNA-mediated downregulation of MMP-9 and uPAR induces G 2 /M arrest in medulloblastoma cells. siRNA for p53 and Chk1 reversed this effect in downstream molecules, resulting in the downregulation of p53 and p21 and the upregulation of cyclin B1 and pCdc2 but had no effect on the levels of MMP-9 and uPAR (Fig. 9) . These results show that the downregulation of MMP-9 and uPAR induces G 2 / M cell-cycle arrest. This study, with further optimization, may provide a simple and highly efficient treatment strategy for medulloblastoma.
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